Bernard Le Foll
Bernard Le Foll
University of Toronto and Centre for Addiction and Mental Health
Verified email at
Cited by
Cited by
Genetics of dopamine receptors and drug addiction: a comprehensive review
B Le Foll, A Gallo, Y Le Strat, L Lu, P Gorwood
Behavioural pharmacology 20 (1), 1-17, 2009
Dopamine D3 receptors expressed by all mesencephalic dopamine neurons
J Diaz, C Pilon, B Le Foll, C Gros, A Triller, JC Schwartz, P Sokoloff
Journal of Neuroscience 20 (23), 8677-8684, 2000
The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders
P Sokoloff, J Diaz, BL Foll, O Guillin, L Leriche, E Bezard, C Gross
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2006
Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence
B Le Foll, SR Goldberg
Journal of Pharmacology and Experimental Therapeutics 312 (3), 875-883, 2005
The association between cannabis use and depression: a systematic review and meta-analysis of longitudinal studies
S Lev-Ran, M Roerecke, B Le Foll, TP George, K McKenzie, J Rehm
Psychological medicine 44 (4), 797-810, 2014
Prevalence and correlates of major depressive episode in pregnant and postpartum women in the United States
Y Le Strat, C Dubertret, B Le Foll
Journal of affective disorders 135 (1-3), 128-138, 2011
Nicotine induces conditioned place preferences over a large range of doses in rats
B Le Foll, SR Goldberg
Psychopharmacology 178 (4), 481-492, 2005
Identification of dopamine D1–D3 receptor heteromers indications for a role of synergistic D1–D3 receptor interactions in the striatum
D Marcellino, S Ferré, V Casadó, A Cortés, B Le Foll, C Mazzola, F Drago, ...
Journal of Biological Chemistry 283 (38), 26016-26025, 2008
The dopamine D3 receptor and drug dependence: effects on reward or beyond?
B Le Foll, SR Goldberg, P Sokoloff
Neuropharmacology 49 (4), 525-541, 2005
A single cocaine exposure increases BDNF and D3 receptor expression: implications for drug-conditioning
B Le Foll, J Diaz, P Sokoloff
Neuroreport 16 (2), 175-178, 2005
Role of the dopamine D3 receptor in reactivity to cocaine‐associated cues in mice
B Le Foll, H Francès, J Diaz, JC Schwartz, P Sokoloff
European Journal of Neuroscience 15 (12), 2016-2026, 2002
Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferences
B Le Foll, SR Goldberg
Neuroreport 15 (13), 2139-2143, 2004
Effects of nicotine in experimental animals and humans: an update on addictive properties
B Le Foll, SR Goldberg
Nicotine Psychopharmacology, 335-367, 2009
Increased dopamine D3 receptor expression accompanying behavioral sensitization to nicotine in rats
B Le Foll, J Diaz, P Sokoloff
Synapse 47 (3), 176-183, 2003
The future of endocannabinoid-oriented clinical research after CB1 antagonists
B Le Foll, DA Gorelick, SR Goldberg
Psychopharmacology 205 (1), 171-174, 2009
Obesity and cannabis use: results from 2 representative national surveys
Y Le Strat, B Le Foll
American journal of epidemiology 174 (8), 929-933, 2011
Granular insular cortex inactivation as a novel therapeutic strategy for nicotine addiction
B Forget, A Pushparaj, B Le Foll
Biological psychiatry 68 (3), 265-271, 2010
Nicotine as a typical drug of abuse in experimental animals and humans
B Le Foll, SR Goldberg
Psychopharmacology 184 (3-4), 367-381, 2006
Psychosocial interventions for cannabis use disorder
PJ Gates, P Sabioni, J Copeland, B Le Foll, L Gowing
Cochrane Database of Systematic Reviews, 2016
Pharmacotherapies for cannabis dependence
K Marshall, L Gowing, R Ali, B Le Foll
Cochrane Database of Systematic Reviews, 2014
The system can't perform the operation now. Try again later.
Articles 1–20